MR spectroscopy in paraneoplastic cerebellar degeneration

Journal of Neuroradiology

Volumn 40, Issue 4, 2013, Pages 310-312

  Hadjivassiliou, Marius ^a   Currie, Stuart ^b   Hoggard, Nigel ^b  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CREATINE; N ACETYLASPARTIC ACID;

ADJUVANT THERAPY; ADULT; ATAXIA; B CELL LYMPHOMA; CASE REPORT; CEREBELLUM VERMIS; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE PROCESSING; LETTER; LONGITUDINAL STUDY; NEUROIMAGING; OVARY ADENOCARCINOMA; PARANEOPLASTIC NEUROPATHY; PROTON NUCLEAR MAGNETIC RESONANCE; WALKING DIFFICULTY;

ASPARTIC ACID; BIOLOGICAL MARKERS; CEREBELLUM; CREATINE; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PARANEOPLASTIC CEREBELLAR DEGENERATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84885866468     PISSN: 01509861     EISSN: 17730406     Source Type: Journal    
DOI: 10.1016/j.neurad.2012.08.003     Document Type: Letter

References (5)

1. Graus F., Delattre J.Y., Antoine J.C., et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004, 75(8):1135-1140.
2. Sutton I., Winer J.B. The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci (Lond) 2002, 102(5):475-486.
3. Furneaux H.M., Rosenblum M.K., Dalmau J., et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990, 322(26):1844-1851.
4. Dalmau J., Rosenfeld M.R. Paraneoplastic syndromes of the CNS. Lancet Neurology 2008, 7(4):327-340.
5. Moffett J., Ross B., Arun P., et al. N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology. Prog Neurobiol 2007, 81:89-131.